What the Alzheimer's drug approval in the U.S. could mean for Canada

The first drug to slow the progression of Alzheimer’s has been approved for use in the U.S., and Canada could follow soon.

Donald Weaver, director and senior scientist at the Krembil Research Institute at the University Health Network, told CTV’s Your Morning on Friday this disease-modifying-drug is not a cure but “a step in the right direction.” “There’s lots of people who think that amyloid is the key to what causes Alzheimer’s disease,” he said.

“You may be able to stay at home six months longer. You may be able to recognize and interact with your family at a more meaningful level,” he said, “It’s a huge amount of time.”

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alzheimer's drug Leqembi has full U.S. FDA approvalU.S. officials granted full approval to a closely watched Alzheimer's drug on Thursday, clearing the way for Medicare and other insurance plans to begin covering the treatment for people with the brain-robbing disease.
Source: CP24 - 🏆 30. / 67 Read more »

U.S. FDA grants standard approval of Eisai/Biogen Alzheimer’s drugU.S. Food and Drug Administration approves Alzheimer’s drug shown to slow progression of brain-wasting disease by 27 per cent
Source: globeandmail - 🏆 5. / 92 Read more »

Alzheimer’s drug Leqembi approved in the U.S.The FDA has granted full approval of the first Alzheimer's drug proven to slow the progression of the disease.
Source: CTVNewsVI - 🏆 28. / 68 Read more »